Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma
Condition: Relapsed or Refractory Synovial Sarcoma Interventions: Drug: OTSA101-DTPA-111In; Drug: OTSA101-DTPA-90Y Sponsor: OncoTherapy Science, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials